CBLL
CeriBell, Inc.NASDAQHealthcare$18.57+0.38%ClosedMarket Cap: $699.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
4.35
P/S
7.68
EV/EBITDA
-13.19
DCF Value
$-40.01
FCF Yield
-6.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
87.9%
Operating Margin
-65.6%
Net Margin
-60.0%
ROE
-31.8%
ROA
-27.3%
ROIC
-32.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $24.8M | 87.3% | $-14.6M | $-13.5M | $-0.36 | — |
| FY 2025 | $89.1M | 87.9% | $-58.4M | $-53.4M | $-1.46 | — |
| Q3 2025 | $22.6M | 88.3% | $-14.6M | $-13.5M | $-0.37 | — |
| Q2 2025 | $21.2M | 88.1% | $-15.0M | $-13.6M | $-0.38 | — |
| Q1 2025 | $20.5M | 87.9% | $-14.2M | $-12.8M | $-0.36 | — |
| Q4 2024 | $18.5M | 87.6% | $-12.9M | $-12.6M | $-0.40 | — |
| FY 2024 | $65.4M | 86.7% | $-39.7M | $-40.5M | $-3.39 | — |
| Q3 2024 | $17.2M | 87.3% | $-9.9M | $-10.4M | $-0.31 | — |
| Q2 2024 | $14.9M | 85.8% | $-8.4M | $-8.7M | $-1.59 | — |
| Q1 2024 | $14.9M | 85.8% | $-8.4M | $-8.7M | $-1.59 | — |
| Q4 2023 | $13.1M | 84.7% | $-8.4M | $-8.3M | $1.74 | — |
| FY 2023 | $45.2M | 84.4% | $-30.0M | $-29.5M | $-1.26 | — |